![]() Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. | ![]() Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | ||
Founding Date | Founding Date 2010 | Founding Date 2017 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Ecublens, CH HQ Cambridge, US | Locations New York, US HQ | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 219% decrease | Employees 524% decrease | Employees 75 |
Funding | |||
Total funding raised | Total funding raised $ 77.6m | Total funding raised N/A | Total funding raised $ 223.5m |

Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View company
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company